Clinical Trial Update: Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of iontophoretic dexamethasone phosphate ophthalmic solution for non-infectious anterior uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Uveitis

Drugs mentioned

• Iontophoretic dexamethasone phosphate ophthalmic solution (dexamethasone phosphate ophthalmic solution)

Snippet

Sponsor: Eyegate Pharmaceuticals, Inc. | Conditions: Anterior Uveitis | Phase 3 | Status: COMPLETED